EU and Swiss regulators strengthen ties with confidentiality agreement
A confidential information exchange agreement will strengthen the relationship between the EMA and Swiss regulators and could save on resources, the agencies say.
Archives for July 26, 2015
AMRI's business risk profile 'weak,' says S&P
A Standards & Poor analyst has rated contract development and manufacturer AMRI as ‘stable,’ but says it lacks the scale and breadth of offerings of its competitors in the CDMO industry.
Update
Teva to buy Allergan's generics biz for $40.5bn
Teva has struck a deal to buy Allergan’s generics business a week after its persistent attempts to acquire Mylan fell through.
Source BioScience to boost stability testing services through $10m acq
DNA sequencing firm Source BioScience will bolster its stability testing and storage services through a proposed acquisition of Select Pharma Laboratories.
Less than a year to risk assess excipients: IPEC Europe develops 'how to' guide
IPEC Europe has reminded drugmakers they have less than a year to risk assess all excipients used in their products under recently introduced EU rules.